Bilal Ahmad1, Naeem Ul Hassan2, Bismillah Sehar3, Falak Zeb4, Dur E Nayab5, Fuad Ahmad Siddiqui2. 1. Department of Medicine, Pak Emirates Military Hospital, Rawalpindi-Pakistan. 2. Department of Medicine, Combined Military Hospital, Rawalpindi-Pakistan. 3. Department of Public Health, National University of Medical Sciences, Rawalpindi-Pakistan. 4. Department of Human Nutrition and Dietetics, National University of Medical Sciences, Rawalpindi-Pakistan falak.zeb@numspak.edu.pk. 5. Department of Paediatrics, Medic Hospital Rawalpindi.
Abstract
Objective: To assess the effect of chloroquine and hydroxychloroquine on cytokine release syndrome (CRS) in adult patients with coronavirus disease 2019 (COVID-19) having mild to moderate symptoms. Methods: This blinded, placebo-controlled, randomized study was conducted in the Department of Medicine, Pak Emirates Military Hospital Rawalpindi, from June 1-15, 2020. A total of 150 hospitalized patients were enrolled after diagnoses with COVID-19 through reverse transcription polymerase chain reaction (RT-PCR). They were divided into three groups: hydroxychloroquine plus general care (HGC, n=50), chloroquine plus general care (CGC, n=50); and only general care (OGC, n=50). The HGC group received treatment with hydroxychloroquine 400 mg every 12 hours for day one and 200 mg for the next 4 days. The CGC group received treatment with chloroquine 250 mg every 12 hours for 7 days. The OGC group was kept as a control with only general care. After 12 days, the patients were screened for development of CRS through detection of interleukin 6 (IL-6) in serum samples by using Roche cobas e411 electrochemiluminescence immunoassay analyzer. Results: The mean duration from onset of symptoms to randomization was 7.65 days (SD = 3.287 days; range, 2-15 days). The mean age of patients was 37.57 (range 19-63) years. Results showed that out of a total 150 patients, only 10 patients (6%, mean=1.93; CI=1.89-1.97, P=0.651) developed CRS in all study groups. Four patients (8%) developed CRS in the HGC group, 2 patients (4%) in the CGC group, and 4 patients (8%) in the OGC group. There was no significant difference in the mean level of CRS among study groups. Conclusion: Administration of hydroxychloroquine and chloroquine has no effect in reducing the development of CRS in patients with COVID-19 having mild to moderate symptoms.
Objective: To assess the effect of chloroquine and hydroxychloroquine on cytokine release syndrome (CRS) in adult patients with coronavirus disease 2019 (COVID-19) having mild to moderate symptoms. Methods: This blinded, placebo-controlled, randomized study was conducted in the Department of Medicine, Pak Emirates Military Hospital Rawalpindi, from June 1-15, 2020. A total of 150 hospitalized patients were enrolled after diagnoses with COVID-19 through reverse transcription polymerase chain reaction (RT-PCR). They were divided into three groups: hydroxychloroquine plus general care (HGC, n=50), chloroquine plus general care (CGC, n=50); and only general care (OGC, n=50). The HGC group received treatment with hydroxychloroquine 400 mg every 12 hours for day one and 200 mg for the next 4 days. The CGC group received treatment with chloroquine 250 mg every 12 hours for 7 days. The OGC group was kept as a control with only general care. After 12 days, the patients were screened for development of CRS through detection of interleukin 6 (IL-6) in serum samples by using Roche cobas e411 electrochemiluminescence immunoassay analyzer. Results: The mean duration from onset of symptoms to randomization was 7.65 days (SD = 3.287 days; range, 2-15 days). The mean age of patients was 37.57 (range 19-63) years. Results showed that out of a total 150 patients, only 10 patients (6%, mean=1.93; CI=1.89-1.97, P=0.651) developed CRS in all study groups. Four patients (8%) developed CRS in the HGC group, 2 patients (4%) in the CGC group, and 4 patients (8%) in the OGC group. There was no significant difference in the mean level of CRS among study groups. Conclusion: Administration of hydroxychloroquine and chloroquine has no effect in reducing the development of CRS in patients with COVID-19 having mild to moderate symptoms.
Authors: Wesley H Self; Matthew W Semler; Lindsay M Leither; Jonathan D Casey; Derek C Angus; Roy G Brower; Steven Y Chang; Sean P Collins; John C Eppensteiner; Michael R Filbin; D Clark Files; Kevin W Gibbs; Adit A Ginde; Michelle N Gong; Frank E Harrell; Douglas L Hayden; Catherine L Hough; Nicholas J Johnson; Akram Khan; Christopher J Lindsell; Michael A Matthay; Marc Moss; Pauline K Park; Todd W Rice; Bryce R H Robinson; David A Schoenfeld; Nathan I Shapiro; Jay S Steingrub; Christine A Ulysse; Alexandra Weissman; Donald M Yealy; B Taylor Thompson; Samuel M Brown; Jay Steingrub; Howard Smithline; Bogdan Tiru; Mark Tidswell; Lori Kozikowski; Sherell Thornton-Thompson; Leslie De Souza; Peter Hou; Rebecca Baron; Anthony Massaro; Imoigele Aisiku; Lauren Fredenburgh; Raghu Seethala; Lily Johnsky; Richard Riker; David Seder; Teresa May; Michael Baumann; Ashley Eldridge; Christine Lord; Nathan Shapiro; Daniel Talmor; Thomas O’Mara; Charlotte Kirk; Kelly Harrison; Lisa Kurt; Margaret Schermerhorn; Valerie Banner-Goodspeed; Katherine Boyle; Nicole Dubosh; Michael Filbin; Kathryn Hibbert; Blair Parry; Kendall Lavin-Parsons; Natalie Pulido; Brendan Lilley; Carl Lodenstein; Justin Margolin; Kelsey Brait; Alan Jones; James Galbraith; Rebekah Peacock; Utsav Nandi; Taylor Wachs; Michael Matthay; Kathleen Liu; Kirsten Kangelaris; Ralph Wang; Carolyn Calfee; Kimberly Yee; Gregory Hendey; Steven Chang; George Lim; Nida Qadir; Andrea Tam; Rebecca Beutler; Joseph Levitt; Jenny Wilson; Angela Rogers; Rosemary Vojnik; Jonasel Roque; Timothy Albertson; James Chenoweth; Jason Adams; Skyler Pearson; Maya Juarez; Eyad Almasri; Mohamed Fayed; Alyssa Hughes; Shelly Hillard; Ryan Huebinger; Henry Wang; Elizabeth Vidales; Bela Patel; Adit Ginde; Marc Moss; Amiran Baduashvili; Jeffrey McKeehan; Lani Finck; Carrie Higgins; Michelle Howell; Ivor Douglas; Jason Haukoos; Terra Hiller; Carolynn Lyle; Alicia Cupelo; Emily Caruso; Claudia Camacho; Stephanie Gravitz; James Finigan; Christine Griesmer; Pauline Park; Robert Hyzy; Kristine Nelson; Kelli McDonough; Norman Olbrich; Mark Williams; Raj Kapoor; Jean Nash; Meghan Willig; Henry Ford; Jayna Gardner-Gray; Mayur Ramesh; Montefiore Moses; Michelle Ng Gong; Michael Aboodi; Ayesha Asghar; Omowunmi Amosu; Madeline Torres; Savneet Kaur; Jen-Ting Chen; Aluko Hope; Brenda Lopez; Kathleen Rosales; Jee Young You; Jarrod Mosier; Cameron Hypes; Bhupinder Natt; Bryan Borg; Elizabeth Salvagio Campbell; R Duncan Hite; Kristin Hudock; Autumn Cresie; Faysal Alhasan; Jose Gomez-Arroyo; Abhijit Duggal; Omar Mehkri; Andrei Hastings; Debasis Sahoo; Francois Abi Fadel; Susan Gole; Valerie Shaner; Allison Wimer; Yvonne Meli; Alexander King; Thomas Terndrup; Matthew Exline; Sonal Pannu; Emily Robart; Sarah Karow; Catherine Hough; Bryce Robinson; Nicholas Johnson; Daniel Henning; Monica Campo; Stephanie Gundel; Sakshi Seghal; Sarah Katsandres; Sarah Dean; Akram Khan; Olivia Krol; Milad Jouzestani; Peter Huynh; Alexandra Weissman; Donald Yealy; Denise Scholl; Peter Adams; Bryan McVerry; David Huang; Derek Angus; Jordan Schooler; Steven Moore; Clark Files; Chadwick Miller; Kevin Gibbs; Mary LaRose; Lori Flores; Lauren Koehler; Caryn Morse; John Sanders; Caitlyn Langford; Kristen Nanney; Masiku MdalaGausi; Phyllis Yeboah; Peter Morris; Jamie Sturgill; Sherif Seif; Evan Cassity; Sanjay Dhar; Marjolein de Wit; Jessica Mason; Andrew Goodwin; Greg Hall; Abbey Grady; Amy Chamberlain; Samuel Brown; Joseph Bledsoe; Lindsay Leither; Ithan Peltan; Nathan Starr; Melissa Fergus; Valerie Aston; Quinn Montgomery; Rilee Smith; Mardee Merrill; Katie Brown; Brent Armbruster; Estelle Harris; Elizabeth Middleton; Robert Paine; Stacy Johnson; Macy Barrios; John Eppensteiner; Alexander Limkakeng; Lauren McGowan; Tedra Porter; Andrew Bouffler; J. Clancy Leahy; Bennet deBoisblanc; Matthew Lammi; Kyle Happel; Paula Lauto; Wesley Self; Jonathan Casey; Matthew Semler; Sean Collins; Frank Harrell; Christopher Lindsell; Todd Rice; William Stubblefield; Christopher Gray; Jakea Johnson; Megan Roth; Margaret Hays; Donna Torr; Arwa Zakaria; David Schoenfeld; Taylor Thompson; Douglas Hayden; Nancy Ringwood; Cathryn Oldmixon; Christine Ulysse; Richard Morse; Ariela Muzikansky; Laura Fitzgerald; Samuel Whitaker; Adrian Lagakos; Roy Brower; Lora Reineck; Neil Aggarwal; Karen Bienstock; Michelle Freemer; Myron Maclawiw; Gail Weinmann; Laurie Morrison; Mark Gillespie; Richard Kryscio; Daniel Brodie; Wojciech Zareba; Anne Rompalo; Michael Boeckh; Polly Parsons; Jason Christie; Jesse Hall; Nicholas Horton; Laurie Zoloth; Neal Dickert; Deborah Diercks Journal: JAMA Date: 2020-12-01 Impact factor: 56.272
Authors: Julie Dyall; Robin Gross; Jason Kindrachuk; Reed F Johnson; Gene G Olinger; Lisa E Hensley; Matthew B Frieman; Peter B Jahrling Journal: Drugs Date: 2017-12 Impact factor: 9.546
Authors: Jun Chen; Danping Liu; Li Liu; Ping Liu; Qingnian Xu; Lu Xia; Yun Ling; Dan Huang; Shuli Song; Dandan Zhang; Zhiping Qian; Tao Li; Yinzhong Shen; Hongzhou Lu Journal: Zhejiang Da Xue Xue Bao Yi Xue Ban Date: 2020-05-25
Authors: Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson Journal: Lancet Date: 2020-03-16 Impact factor: 79.321